Log in

NASDAQ:TRNXTaronis Technologies Stock Price, Forecast & News

-0.01 (-6.27 %)
(As of 04/3/2020 04:00 PM ET)
Today's Range
Now: $0.15
50-Day Range
MA: $0.34
52-Week Range
Now: $0.15
Volume35.28 million shs
Average Volume15.47 million shs
Market Capitalization$4.95 million
P/E RatioN/A
Dividend YieldN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars

Industry, Sector and Symbol

Industry Special industry machinery, not elsewhere classified
SectorBusiness Services
Current SymbolNASDAQ:TRNX



Sales & Book Value

Annual Sales$9.71 million
Book Value$14.95 per share


Net Income$-15,040,000.00
Net Margins-129.20%


Market Cap$4.95 million
Next Earnings Date5/18/2020 (Estimated)
OptionableNot Optionable

Receive TRNX News and Ratings via Email

Sign-up to receive the latest news and ratings for TRNX and its competitors with MarketBeat's FREE daily newsletter.

Taronis Technologies (NASDAQ:TRNX) Frequently Asked Questions

How has Taronis Technologies' stock been impacted by COVID-19 (Coronavirus)?

Taronis Technologies' stock was trading at $0.2278 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TRNX stock has decreased by 34.4% and is now trading at $0.1495. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Taronis Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Taronis Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Taronis Technologies.

When is Taronis Technologies' next earnings date?

Taronis Technologies is scheduled to release its next quarterly earnings announcement on Monday, May 18th 2020. View our earnings forecast for Taronis Technologies.

How were Taronis Technologies' earnings last quarter?

Taronis Technologies Inc (NASDAQ:TRNX) announced its earnings results on Wednesday, November, 20th. The company reported ($0.49) earnings per share for the quarter. The business earned $5.32 million during the quarter. Taronis Technologies had a negative return on equity of 78.94% and a negative net margin of 129.20%. View Taronis Technologies' earnings history.

Has Taronis Technologies been receiving favorable news coverage?

News headlines about TRNX stock have trended very negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Taronis Technologies earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutTaronis Technologies.

Are investors shorting Taronis Technologies?

Taronis Technologies saw a increase in short interest in March. As of March 13th, there was short interest totaling 1,985,200 shares, an increase of 17.5% from the February 27th total of 1,690,000 shares. Based on an average trading volume of 11,632,400 shares, the days-to-cover ratio is currently 0.2 days. Currently, 7.0% of the shares of the stock are sold short. View Taronis Technologies' Current Options Chain.

Who are some of Taronis Technologies' key competitors?

What other stocks do shareholders of Taronis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Taronis Technologies investors own include FuelCell Energy (FCEL), Actinium Pharmaceuticals (ATNM), Titan Pharmaceuticals (TTNP), Canopy Growth (CGC), Correvio Pharma (CORV), Inovio Pharmaceuticals (INO), Inpixon (INPX), Nabriva Therapeutics (NBRV), NIO (NIO) and AcelRx Pharmaceuticals (ACRX).

What is Taronis Technologies' stock symbol?

Taronis Technologies trades on the NASDAQ under the ticker symbol "TRNX."

How do I buy shares of Taronis Technologies?

Shares of TRNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Taronis Technologies' stock price today?

One share of TRNX stock can currently be purchased for approximately $0.15.

How big of a company is Taronis Technologies?

Taronis Technologies has a market capitalization of $4.95 million and generates $9.71 million in revenue each year.  View additional information about Taronis Technologies.

What is Taronis Technologies' official website?

The official website for Taronis Technologies is http://www.magnegas.com/.

How can I contact Taronis Technologies?

Taronis Technologies' mailing address is 300 W. CLARENDON AVENUE SUITE 230, PHOENIX AZ, 85013. The company can be reached via phone at 866-370-3835 or via email at [email protected]

This page was last updated on 4/4/2020 by MarketBeat.com Staff

Featured Article: FinTech

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel